William Clark

2017 - Genocea Biosciences

In 2017, William Clark earned a total compensation of $1.5M as President and Chief Executive Officer at Genocea Biosciences, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$137,500
Option Awards$890,755
Salary$493,333
Other$5,425
Total$1,527,013

Clark received $890.8K in option awards, accounting for 58% of the total pay in 2017.

Clark also received $137.5K in non-equity incentive plan, $493.3K in salary and $5.4K in other compensation.

Rankings

In 2017, William Clark's compensation ranked 6,885th out of 14,666 executives tracked by ExecPay. In other words, Clark earned more than 53.1% of executives.

ClassificationRankingPercentile
All
6,885
out of 14,666
53rd
Division
Manufacturing
2,553
out of 5,768
56th
Major group
Chemicals And Allied Products
824
out of 2,074
60th
Industry group
Drugs
638
out of 1,730
63rd
Industry
Biological Products, Except Diagnostic Substances
117
out of 316
63rd
Source: SEC filing on April 24, 2018.

Clark's colleagues

We found five more compensation records of executives who worked with William Clark at Genocea Biosciences in 2017.

2017

Jonathan Poole

Genocea Biosciences

Chief Financial Officer

2017

Seth Hetherington

Genocea Biosciences

Chief Medical Officer

2017

Jessica Fletchner

Genocea Biosciences

Chief Scientific Officer

2017

Eric Hoffman

Genocea Biosciences

Former Chief Business Officer

2017

Pamela Carroll

Genocea Biosciences

Senior Vice President, Immuno, Oncology

News

In-depth

You may also like